Pro Forma Financial Statement - Schedule of Business Combination Pro Forma Information (Details) (Parenthetical) - $ / shares |
Jun. 30, 2021 |
Dec. 31, 2020 |
|---|---|---|
| Condensed Cash Flow Statements, Captions [Line Items] | ||
| Common Stock, No Par Value | $ 0.001 | $ 0.001 |
| Common Stock, Shares Authorized | 100,000,000 | 100,000,000 |
| Common Stock, Shares, Outstanding | 0 | 28,553,307 |
| Supera Pharmaceuticals Inc [Member] | ||
| Condensed Cash Flow Statements, Captions [Line Items] | ||
| Common Stock, No Par Value | $ 0.0001 | |
| Common Stock, Shares Authorized | 100,000,000 | |
| Common Stock, Shares, Outstanding | 73,991,413 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Face amount per share of no-par value common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|